What Influences Patient Outcome in Obstructive Airway Disease?

Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01221480

Enrollment

5977

Registered

2010-10-15

Start date

2010-08-31

Completion date

2010-10-31

Last updated

2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Data collected through TARDIS database

Exclusion criteria

* History of asthma or malignancy. Less than 50 years of age

Design outcomes

Primary

Measure	Time frame	Description
All-cause Mortality	3000 days	All-cause Mortality

Secondary

Measure	Time frame	Description
Hospital Admissions	3000 days	Hospital Admissions
COPD exacerbations	3000 days	COPD exacerbations

Outcome results